The panelist discusses Vowst, an FDA-approved live microbiota therapeutic that works by introducing healthy donor-derived gut ...

Clostridioides difficile is a type of bacteria that often affects people who have been taking antibiotics, GST Micro LLC ...

Antibiotics can disrupt gut microbiota, leading to potential recurrences of Clostridioides difficile infections (CDI). New therapies like fecal microbiota transplantation (FMT) and monoclonal ...

Purpose The pharmacology, clinical efficacy, safety, dosage and administration, and place in therapy of fidaxomicin for the treatment of Clostridium difficile infection (CDI) are reviewed.

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Clostridioides difficile (C. diff) is a type of bacteria that may lead to severe diarrhea and colon inflammation. It’s often associated with taking antibiotics. According to the Centers for ...

Clostridioides difficile (C. diff), a type of bacteria which often affects people who have taken antibiotics, is responsible for approximately 2,000 deaths annually in the UK. Researchers from the ...

with its lead antibiotic candidate, ibezapolstat, preparing to advance to international Phase 3 clinical trials to treat patients with C. difficile Infection (CDI). The Company today announced updates ...

While it is typically controlled by beneficial bacterial flora, antibiotics can sometimes strip the body of those protections ...

However, if these people fall ill and are prescribed broad spectrum antibiotics C-diff can become a problem – that’s because the antibiotics wipe out the normal gut bacteria, allowing the ...

C. diff can cause infection if the balance of bowel bacteria changes - after taking antibiotics, for example. The transplants transfer beneficial gut bacteria from a healthy donor's faeces.